{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:24:01Z","timestamp":1740126241546,"version":"3.37.3"},"reference-count":35,"publisher":"Wiley","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1034,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatol Ther"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1111\/dth.12009","type":"journal-article","created":{"date-parts":[[2012,12,13]],"date-time":"2012-12-13T16:53:31Z","timestamp":1355417611000},"page":"S1-S9","source":"Crossref","is-referenced-by-count":5,"special_numbering":"supplement S1","title":["Multidisciplinary approach to R&D in vitiligo, a neglected skin disease"],"prefix":"10.1155","volume":"25","author":[{"given":"Yan","family":"Valle","sequence":"first","affiliation":[{"name":"VR Foundation; New York; New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torello M","family":"Lotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Hercogova","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology; 2nd Medical School; Charles University of Prague; Prague; Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Pathology; New Jersey Medical School; Newark; New Jersey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor V.","family":"Korobko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,12,13]]},"reference":[{"key":"10.1111\/dth.12009-BIB0001|dth12009-cit-0001","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1001\/archderm.1966.01600240110023","article-title":"White spots in biblical times. A background for the dermatologist for participation in discussions of current revisions of the bible","volume":"93","author":"Goldman","year":"1966","journal-title":"Arch Dermatol"},{"key":"10.1111\/dth.12009-BIB0002|dth12009-cit-0002","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/9780470760116.ch3","volume-title":"Vitiligo","author":"Kopera","year":"2000"},{"key":"10.1111\/dth.12009-BIB0003|dth12009-cit-0003","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2133.2012.10839.x","article-title":"Vitiligo: new insights","volume":"166","author":"Picardo","year":"2012","journal-title":"Br J Dermatol"},{"first-page":"1","volume-title":"Vitiligo: problems and solutions","year":"2004","key":"10.1111\/dth.12009-BIB0004|dth12009-cit-0004"},{"key":"10.1111\/dth.12009-BIB0005|dth12009-cit-0005","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0738-081X(97)00128-4","article-title":"The epidemiology and genetics of vitiligo","volume":"15","author":"Nordlund","year":"1997","journal-title":"Clin Dermatol"},{"volume-title":"Vitiligo therapeutics - pipeline assessment and market forecasts to 2019","year":"2012","author":"Global Data","key":"10.1111\/dth.12009-BIB0006|dth12009-cit-0006"},{"key":"10.1111\/dth.12009-BIB0007|dth12009-cit-0007","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1755-148X.2012.00997.x","article-title":"Revised classification\/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference","volume":"25","author":"Ezzedine","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"issue":"1","key":"10.1111\/dth.12009-BIB0008|dth12009-cit-0008","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003263.pub4","article-title":"Interventions for vitiligo","author":"Whitton","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/dth.12009-BIB0009|dth12009-cit-0009","doi-asserted-by":"crossref","unstructured":"Adams C Brantner V Spending on new drug development 2008 http:\/\/ssrn.com\/abstract=869765 http:\/\/dx.doi.org\/10.2139\/ssrn.869765","DOI":"10.2139\/ssrn.869765"},{"key":"10.1111\/dth.12009-BIB0010|dth12009-cit-0010","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.drudis.2008.02.005","article-title":"Impact of non-profit organizations on drug discovery: opportunities, gaps, solutions","volume":"13","author":"Matter","year":"2008","journal-title":"Drug Discov Today"},{"key":"10.1111\/dth.12009-BIB0011|dth12009-cit-0011","first-page":"175","article-title":"Drug discovery and development for neglected diseases: the DNDi model","volume":"5","author":"Chatelain","year":"2011","journal-title":"Drug Des Devel Ther"},{"volume-title":"Wikinomics: how mass collaboration changes everything","year":"2006","author":"Tapscott","key":"10.1111\/dth.12009-BIB0012|dth12009-cit-0012"},{"key":"10.1111\/dth.12009-BIB0013|dth12009-cit-0013","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11095-010-0059-0","article-title":"Reaching out to collaborators: crowdsourcing for pharmaceutical research","volume":"27","author":"Ekins","year":"2010","journal-title":"Pharm Res"},{"key":"10.1111\/dth.12009-BIB0014|dth12009-cit-0014","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrd2201","article-title":"Drugs for bad bugs: confronting the challenges of antibacterial discovery","volume":"6","author":"Payne","year":"2007","journal-title":"Nat Rev Drug Discov"},{"volume-title":"Pharma 2020: virtual R&D - which path will you take?","year":"2008","author":"PricewaterhouseCoopers International Limited","key":"10.1111\/dth.12009-BIB0015|dth12009-cit-0015"},{"key":"10.1111\/dth.12009-BIB0016|dth12009-cit-0016","first-page":"35","article-title":"All eyes on early-stage assets","volume":"100","author":"Chan","year":"2006","journal-title":"Scrip"},{"volume-title":"Pharma 2020: challenging business model","year":"2009","author":"PricewaterhouseCoopers International Limited","key":"10.1111\/dth.12009-BIB0017|dth12009-cit-0017"},{"key":"10.1111\/dth.12009-BIB0018|dth12009-cit-0018","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1089\/bio.2010.7302","article-title":"The role of biobanking in rare diseases: European consensus expert group report","volume":"7","author":"Lochm\u00fcller","year":"2009","journal-title":"Biopreserv Biobank"},{"key":"10.1111\/dth.12009-BIB0019|dth12009-cit-0019","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/15265160802513093","article-title":"Public expectations for return of results from large-cohort genetic research","volume":"8","author":"Murphy","year":"2008","journal-title":"Am J Bioeth"},{"key":"10.1111\/dth.12009-BIB0020|dth12009-cit-0020","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1365-2133.2011.10798.x","article-title":"The association of functional polymorphisms in the aryl hydrocarbon receptor (AHR) gene with the risk of vitiligo in Han Chinese populations","volume":"166","author":"Wang","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1111\/dth.12009-BIB0021|dth12009-cit-0021","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng.2272","article-title":"Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo","volume":"44","author":"Jin","year":"2012","journal-title":"Nat Genet"},{"key":"10.1111\/dth.12009-BIB0022|dth12009-cit-0022","unstructured":"Nobel S Biobanks - Integration of human information to improve health 2008"},{"key":"10.1111\/dth.12009-BIB0023|dth12009-cit-0023","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1177\/1740774510373492","article-title":"T1DGC: biobanking, consent, and commercialization in international genetics research: the Type 1 Diabetes Genetics Consortium","volume":"7","author":"Hall","year":"2010","journal-title":"Clin Trials"},{"key":"10.1111\/dth.12009-BIB0024|dth12009-cit-0024","first-page":"82","article-title":"Cloud Medical Research Management (MRM): a bio-IT tool for correlative studies in dermatology","volume":"1","author":"Valle","year":"2011","journal-title":"Treat Strateg (Dermatol)"},{"key":"10.1111\/dth.12009-BIB0025|dth12009-cit-0025","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/gepi.20589","article-title":"The use of phenome-wide association studies (PheWAS) for exploration of novel genotype-phenotype relationships and pleiotropy discovery","volume":"35","author":"Pendergrass","year":"2011","journal-title":"Genet Epidemiol"},{"key":"10.1111\/dth.12009-BIB0026|dth12009-cit-0026","doi-asserted-by":"crossref","first-page":"e1000993","DOI":"10.1371\/journal.pgen.1000993","article-title":"Web-based, participant-driven studies yield novel genetic associations for common traits","volume":"6","author":"Eriksson","year":"2010","journal-title":"PLoS Genet"},{"key":"10.1111\/dth.12009-BIB0027|dth12009-cit-0027","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/ije\/dym282","article-title":"Biorepositories - at the bleeding edge","volume":"37","author":"Manolio","year":"2008","journal-title":"Int J Epidemiol"},{"issue":"Suppl. 1","key":"10.1111\/dth.12009-BIB0028|dth12009-cit-0028","doi-asserted-by":"crossref","first-page":"i46","DOI":"10.1093\/ije\/dyn031","article-title":"Design and implementation of a high throughput biological sample processing facility using modern manufacturing principles","volume":"37","author":"Downey","year":"2008","journal-title":"Int J Epidemiol"},{"key":"10.1111\/dth.12009-BIB0029|dth12009-cit-0029","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/ije\/dym276","article-title":"The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine","volume":"37","author":"Elliott","year":"2008","journal-title":"Int J Epidemiol"},{"issue":"Suppl. 1","key":"10.1111\/dth.12009-BIB0030|dth12009-cit-0030","doi-asserted-by":"crossref","first-page":"i2","DOI":"10.1093\/ije\/dyn019","article-title":"The UK Biobank sample handling and storage validation studies","volume":"37","author":"Peakman","year":"2008","journal-title":"Int J Epidemiol"},{"key":"10.1111\/dth.12009-BIB0031|dth12009-cit-0031","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrg3208","article-title":"Mining electronic health records: towards better research applications and clinical care","volume":"13","author":"Jensen","year":"2012","journal-title":"Nat Rev Genet"},{"key":"10.1111\/dth.12009-BIB0032|dth12009-cit-0032","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/00008571-200409000-00002","article-title":"Extracting and characterizing gene-drug relationships from the literature","volume":"14","author":"Chang","year":"2004","journal-title":"Pharmacogenetics"},{"key":"10.1111\/dth.12009-BIB0033|dth12009-cit-0033","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2174\/1874136300802010018","article-title":"Internet in drug design and discovery","volume":"2","author":"Tetko","year":"2008","journal-title":"Open Appl Inform J"},{"key":"10.1111\/dth.12009-BIB0034|dth12009-cit-0034","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.drudis.2012.02.005","article-title":"Orphan drug development: an economically viable strategy for biopharma R&D","volume":"17","author":"Meekings","year":"2012","journal-title":"Drug Discov Today"},{"key":"10.1111\/dth.12009-BIB0035|dth12009-cit-0035","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/j.1365-4632.2011.05377.x","article-title":"A review of the worldwide prevalence of vitiligo in children\/adolescents and adults","volume":"51","author":"Kr\u00fcger","year":"2012","journal-title":"Int J Dermatol"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdth.12009","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/dth.12009\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T17:59:39Z","timestamp":1671818379000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dth.12009"}},"subtitle":["New interest on neglected diseases therapies"],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":35,"URL":"https:\/\/doi.org\/10.1111\/dth.12009","relation":{},"ISSN":["1396-0296"],"issn-type":[{"type":"print","value":"1396-0296"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}